Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Serenoa repens para la hiperplasia prostática benigna

Esta versión no es la más reciente

ver la versión actual 22 junio 2023

Información

DOI:
https://doi.org/10.1002/14651858.CD001423.pub3Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 12 diciembre 2012see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Urología

Copyright:
  1. Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • James Tacklind

    Correspondencia a: Center for Chronic Disease Outcomes Research (111‐0), Minneapolis Veterans Affairs Medical Center, Minneapolis, USA

    [email protected]

    [email protected]

  • Roderick MacDonald

    General Internal Medicine (111‐0), VAMC, Minneapolis, USA

  • Indy Rutks

    Department of Internal Medicine (111‐0), VAMC, Minneapolis, USA

  • Judith U Stanke

    Bio‐Medical Library, University of Minnesota, Minneapolis, USA

  • Timothy J Wilt

    General Internal Medicine (111‐0), VAMC, Minneapolis, USA

Contributions of authors

JT searched for trials and wrote the analysis. RM and TW edited the manuscript. IR and JUS wrote the search strategy.

Sources of support

Internal sources

  • Management Decision and Research Center‐Department of Veterans Affairs HSRD, USA.

  • Minneapolis/VISN‐13 Center for Chronic Diseases Outcomes Research (CCDOR), USA.

External sources

  • The Cochrane Complementary Medicine Field bursary award, USA.

    The Cochrane review group Prostatic Diseases and Urologic Cancers received a one‐time payment from the Cochrane Complementary Medicine Field to update this review.

  • Grant no. 5R01DK63300‐4, USA.

    Editing support was in part provided by the National Institutes of Health (NIH), and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

Declarations of interest

None declared.

Acknowledgements

This work was partially funded by Grant Number R24 AT001293 from the National Center for Complementary and Alternative Medicine (NCCAM), and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grant Number 1R01 DK063300‐01A2. Authors are employees of the US Department of Veterans Affairs. The contents of this systematic review are solely the responsibility of the authors and do not necessarily represent the official views of the NCCAM, the National Institutes of Health, or the Department of Veterans Affairs. We also wish to thank Maurizio Tiso, Margaret Haugh, Rich Crawford, Tatyana Shamilyan, Philipp Dahm, Yelena Slinin, and Joan Barnes for their work in translating and abstracting data from the non‐English language studies.

Version history

Published

Title

Stage

Authors

Version

2023 Jun 22

Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement

Review

Juan VA Franco, Leonel Trivisonno, Nadia J Sgarbossa, Gustavo Ariel Alvez, Cecilia Fieiras, Camila Micaela Escobar Liquitay, Jae Hung Jung

https://doi.org/10.1002/14651858.CD001423.pub4

2012 Dec 12

<i>Serenoa repens</i> for benign prostatic hyperplasia

Review

James Tacklind, Roderick MacDonald, Indy Rutks, Judith U Stanke, Timothy J Wilt

https://doi.org/10.1002/14651858.CD001423.pub3

2009 Apr 15

<i>Serenoa repens</i> for benign prostatic hyperplasia

Review

James Tacklind, Roderick MacDonald, Indy Rutks, Judith U Stanke, Timothy J Wilt

https://doi.org/10.1002/14651858.CD001423.pub2

2002 Jul 22

Serenoa repens for benign prostatic hyperplasia

Review

Timothy Wilt, Areef Ishani, Roderick MacDonald

https://doi.org/10.1002/14651858.CD001423

Differences between protocol and review

For this update (2012) we added adverse events (harms) to Secondary outcomes.

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.